Story · Medicine & Biotech · Mind & Brain

Genprex bets on a one-time gene therapy for diabetes (Part 3 of 3)

1 outlet · first reported by Labiotech.eu 12d ago

Coverage, in order

  1. 12d ago
    Labiotech.eu Germany indie podcast
    Genprex bets on a one-time gene therapy for diabetes (Part 3 of 3)

    In part three of our series, I spoke with Ryan Confer, President and CEO of Genprex, about the company’s move from cancer into diabetes.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.